Abstract
Background
Deep brain stimulation (DBS) is a commonly performed surgical technique for the treatment of movement disorders, and recent surgical trials concerning the treatment of a wider range of disorders have recently been published. Despite DBS being non-ablative and minimally invasive, numerous complications and side effects have been recorded. In particular, concerning the growing interest in novel indications for DBS, an enthusiastic approach has put neurosurgeons at risk of underestimating some of the complications that might be associated with specific characters of the treated disease.
Objective
Our objective was to evaluate hardware failures and rates of infective complications in correlation to the different indications to DBS, in order to ascertain whether DBS in Tourette syndrome (TS) is characterized by specific risks and pitfalls.
Methods
We retrospectively reviewed our experience of 531 procedures on 272 patients treated for various movement disorders, among which 39 patients were treated for conservative treatmentrefractory TS.
Results
A statistically significant association of infective complications was found with the TS subgroup.
Conclusions
It is our belief that specific behavioral characters of the TS patients may be put into association with this specific complication and need to be considered carefully when indicating DBS as treatment of choice for these patients.
Similar content being viewed by others
References
Gross RE (2004) Deep brain stimulation in the treatment of neurological and psychiatric disease. Expert Rev Neurother 4:465–478
Porta M, Servello D, Sassi M, Brambilla A (2005) Advances in Gilles de la Tourette Syndrome: preliminary results in a cohort of 10 patients treated with DBS. In: van Hilten B, Nuttin B (eds) Proceedings for Neurosciences, Springer
Vandewalle V, van der Linden CHR, Groenewegen HJ, Caemaert J (1999) Stereotactic treatment of Gilles de la Tourette Syndrome by high frequency stimulation of thalamus. Lancet 353:724
Bhatia S, Zhang K, Oh M, Angle C, Whiting D (2010) Infections and hardware salvage after deep brain stimulation surgery: a single-center study and review of the literature. Stereotact Funct Neurosurg 88(3):147–155, [Epub ahead of print] PMID 20357522
Chan DT, Zhu XL, Yeung JH, Mok VC, Wong E, Lau C, Poon WS (2009) Complications of deep brain stimulation: a collective review. Asian J Surg 32(4):258–263
Miller PM, Gross RE (2009) Wire tethering or ‘bowstringing’ as a long-term hardware-related complication of deep brain stimulation. Stereotact Funct Neurosurg 87(6):353–359
Chou YC, Lin SZ, Hsieh WA, Lin SH, Lee CC, Hsin YL, Yen PS, Lee CW, Chiu WT, Chen SY (2007) Surgical and hardware complications in subthalamic nucleus deep brain stimulation. J Clin Neurosci 14(7):643–649
Fytagoridis A, Blomstedt P (2010) Complications and side effects of deep brain stimulation in the posterior subthalamic area. Stereotact Funct Neurosurg 88(2):88–93
Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J (2007) Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 106(4):621–625
Paluzzi A, Belli A, Bain P, Liu X, Aziz TM (2006) Operative and hardware complications of deep brain stimulation for movement disorders. Br J Neurosurg 20(5):290–5
Seijo FJ, Alvarez-Vega MA, Gutierrez JC, Fdez-Glez F, Lozano B (2007) Complications in subthalamic nucleus stimulation surgery for treatment of Parkinson’s disease. Review of 272 procedures. Acta Neurochir (Wien) 149(9):867–875, discussion 876
Sillay KA, Larson PS, Starr PA (2008) Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 62(2):360–366, discussion 366–367
Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destée A, Defebvre L, Krystkowiak P (2007) Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 61(2):297–304, discussion 304–5
Voges J, Waerzeggers Y, Maarouf M, Lehrke R, Koulousakis A, Lenartz D, Sturm V (2006) Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery—experiences from a single centre. Neurol Neurosurg Psychiatry 77:868–872
Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF (2009) Immunopathogenic mechanisms in Tourette Syndrome: a critical review. Mov Disord 24(9):1267–1279
Kawikova I, Leckman JF, Kronig H, Katsovich L, Bessen DE, Ghebremichael M, Bothwell AL (2007) Decreased number of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61:273–278
Ferrari M, Termine C, Franciotta D, Castiglioni E, Pagani A, Lanzi G, Marino F, Lecchini S, Cosentino M, Balottin U (2008) Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients. J Psychiat Res 43:24–29
Acknowledgements
We would like to acknowledge Ms Tiziana De Santo for support concerning methods and data evaluation, and Ms Olga Lee Rachello for language revision.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Servello, D., Sassi, M., Gaeta, M. et al. Tourette syndrome (TS) bears a higher rate of inflammatory complications at the implanted hardware in deep brain stimulation (DBS). Acta Neurochir 153, 629–632 (2011). https://doi.org/10.1007/s00701-010-0851-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-010-0851-y